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I N T R O D U C T I O N
According to the US Renal Data System, 7-20% of patients on dialysis have chronic obstructive pulmonary disease (COPD) that includes chronic bronchitis and emphysema [1] [2] [3] . In the UK, its prevalence among incident patients in 2013-14 was 7.6% [4] . A nationally representative sample of US adults [National Health and Nutrition Examination Surveys (NHANES)] reported lower forced expiratory volume (FEV1) and forced vital capacity (FVC) in patients with, compared with without, chronic kidney disease (CKD) [5] . In Taiwan, the population with COPD is reported to be at higher risk of CKD [hazard ratio (HR) 1.16, 95% confidence interval (CI) 1.53-1.75] [6] .
The association between respiratory disease and kidney disease may result from common causes, as in systemic vasculitis [7, 8] , or more direct pathways, such as lung cancer and membranous nephropathy or renal cyclosporine toxicity after lung transplantation [9] . They also share common risk factors, including tobacco use, occupational exposure [10, 11] and advanced age. COPD, like CKD, is associated with metabolic syndrome [12] . Whatever the initial cause, the interaction between kidney and pulmonary injuries may be related to subclinical inflammation, endothelial dysfunction or more specific pathways such as sympathetic RAAS activation or metabolic disorder in kidney disease and hypoxia hypercapnia in pulmonary disease [13] .
Although numerous studies have examined the effect of sleep apnoea on outcomes of dialysis patients, we have found few studies about COPD or, more generally, chronic respiratory diseases (CRD) that include mainly COPD, asthma, occupational lung diseases and pulmonary hypertension. In patients with Stages 3 and 4 CKD [14] or on dialysis [3] , COPD is associated with a higher risk of death. No studies have examined the effect of CRD on hospital admissions or access to renal transplantation. We therefore sought to describe patients with CRD and end-stage renal disease (ESRD) and their outcomes after dialysis start, compared with patients without CRD. We focus especially on causes of death, access to renal transplantation and causes of hospital admissions.
M A T E R I A L S A N D M E T H O D S

Population
The French REIN registry is intended to include all ESRD patients on renal replacement therapy (RRT)-either dialysis or transplantation-living in France, including the overseas districts. Patients with a diagnosis of acute renal failure are excluded, that is, those who recover all or some renal function within 45 days or are considered by experts to have acute failure when they die before 45 days. The details of its organizational principles and quality control have been described elsewhere [15] . This analysis includes all adults aged 18 years who began dialysis from 2008 to 2013.
Data
Baseline information at dialysis initiation included age, gender, comorbidities, mobility status (walks without help, needs assistance for transfers or totally dependent for transfers), body mass index (BMI), tobacco use, haemoglobin and serum albumin the month preceding dialysis start, context of first dialysis (emergency or planned), first dialysis technique (haemodialysis or peritoneal dialysis) and residual renal function, estimated with the CKEPI formula. This study analyses 10 comorbidities: diabetes, congestive heart failure, ischaemic heart disease, peripheral vascular disease, aortic aneurysm, cerebrovascular disease, dysrhythmia, active malignancy, cirrhosis and severe behavioural disorders (defined as including dementia, psychosis or severe neurosis that may affect functional status or adherence to treatment).
CRD is defined in the REIN registry user guide as the presence of chronic respiratory insufficiency (PaO 2 <60 mmHg, pH of 7.37-7.43, regardless of carbon dioxide level) or COPD, defined as productive cough for at least 2 years, or any severe pulmonary disease with a specific treatment responsible for repeated hospitalizations.
Annual follow-up is recorded in the registry. Deaths, waiting list registration and renal transplantation were recorded on occurrence from the first day of dialysis through the end of 2014. A principal cause was recorded for each death and optionally three associated causes. Nephrologists completing death certificates were initially offered a limited list of causes, but could use all of International Classification of Diseases, Tenth Revision (ICD-10). The completeness of patient and event registration is periodically verified by clinical research assistants by an on-site visit in each dialysis centre.
Outcome
The primary outcome was mortality, compared between people with and without CRD. Nephrologists are required to report deaths to the REIN registry on occurrence. Because research assistants check vital status every year for all patients, event registration can be considered exhaustive. Principal causes of death were arranged in six groups for analysis: respiratory disease, cardiovascular disease, infection, malignancy, cachexia and other causes. Other outcomes analysed were time from dialysis start to wait-listing for transplantation and from dialysis start to the first renal graft in patients under 75 years of age. The numbers of admissions and of hospital days were analysed according to principal diagnosis.
Missing data
Because values were missing for relevant covariates (Table 1) , multiple imputations by a Markov-chain Monte Carlo approach with uninformative prior information was used to obtain substitutes (SAS MI procedure) [16] . This procedure was repeated 20 times to obtain 20 draws for each missing value in 20 distinct data sets. The relative efficiency for each item exceeded 0.99. The SAS MIANALYZE procedure was used to combine the results of the analyses throughout these imputed data sets.
Information about hospitalizations was extracted from the exhaustive French hospital discharge database [Programme de Médicalisation des Systèmes d'Information (PMSI)], which makes available for epidemiological studies anonymized data with limited social and demographic information and medical information about the principal diagnosis leading to admission, underlying comorbidities and possible complications. We first selected all hospitalizations from 2008 to 2013 for patients who had at least one hospitalization for ESRD treatment (i.e. with a diagnosis-related group or medical act related to maintenance dialysis or renal transplantation) during this period: 17 951 695 admissions. Hospitalizations in 2014 were not available. No direct personal identifiers are available in the PMSI database, and there is no unique identifier between it and the REIN registry database. We therefore proceeded to a stepwise indirect linkage between them. To ensure privacy and confidentiality [17] , no identifying information was used for linkage, but only demographic data: gender; age (in years); residency code; a national hospital identifier; year and month of dialysis start for REIN; and year and month of hospital discharge for PMSI.
Statistical analysis
Baseline characteristics of the two groups (ESRD patients with or without CRD) were expressed as frequencies and percentages in the overall population and according to age group. They were compared with the chi-square test and logistic regression to adjust for age and gender.
Survival in the two groups was compared with a log-rank test and is presented by Kaplan-Meier curves. The HR for CRD was first analysed with a Cox proportional-hazard regression adjusted for gender, age and comorbidities. Mortality among dialysis patients was analysed with an adjusted (cause-specific) Cox proportional-hazard regression censored at transplantation.
The cumulative incidence of specific causes of death was analysed with a subdistribution hazard (Fine and Gray) model to take into account the competing risks between various causes of death. The effect of CRD on specific cause of death was analysed with an adjusted (cause-specific) Cox proportional hazard regression censored at other cause of death [18] .
The cumulative incidence rates of wait-listing for transplantation during the first 36 months of dialysis and of a first transplantation during the first 48 months in patients younger than 75 years were also analysed with subdistribution hazard models to take into account death. The effect of CRD on first transplantation in patients under 75 years was analysed with an adjusted (cause-specific) Cox proportional hazard regression censored at death. Because of the interaction with age, the analysis is presented by age group. We found no significant interaction between CRD and gender.
Results are reported, when appropriate, as subdistribution cumulative incidence rates or cause-specific HRs (csHRs) with their 95% CIs.
Patient-years at risk, and numbers of hospitalizations and of hospital days were calculated from the first day of dialysis through the end of 2013 or renal transplantation. Hospital daycare accounted for 0.5 day. Hospital causes of admission were categorized as cardiovascular disease, infection, pulmonary disease, cancer and ESRD related, based on the principal diagnosis (the ICD-10, Clinical Modification). Rates were compared after adjustment with the direct method based on 5-year age classes and gender, with the entire cohort as reference. 
Statistical analyses were computed with SAS software, in particular the PHREG procedure and the %cuminc macro.
R E S U L T S
This analysis included 52 797 adults aged 18 years and older who began dialysis during 2008-13 and for whom information about a possible respiratory disease was available (1952 patients, i.e. 3.6% of the cohort, were excluded because of missing data for this item). After exclusion of 56 patients who underwent a pulmonary transplantation before starting dialysis, our study finally included 52 741 individuals, 6496 (12.3%) of whom had a respiratory disease at dialysis start. Among the 6496 patients with CRD, 1273 had either oxygenotherapy or home ventilatory assistance (19.6%). Median follow-up time was 2.6 years [interquartile range (IQR) 1.4-4.2] in the group without CRD and 1.9 years (IQR 1.0-3.4) in the group with it.
Patients with CRD were older, more often male, and more often a former or current smoker; they had comorbidities more often. They started less often with peritoneal dialysis, more often on an emergency basis and with a higher estimated glomerular filtration rate (eGFR) ( Table 1 ). Those differences (Figure 1 (Table 2) .
Patients with CRD had a higher cumulative incidence of death due to respiratory disease, cardiovascular disease and infection (Table 3) ; their risk of dying from a respiratory disease was 8.8 times higher than for those without CRD. Their csHR for death from infection, adjusted for age, gender and comorbidities, was also significant but less so.
By the end of 2014, 616 patients with CRD (9%) and 12 937 patients without CRD (28%) had been wait-listed for a renal graft. The cumulative incidence rates of being wait-listed at 36 months and being transplanted at 48 months decreased with age and were always lower in those with CRD (Table 4) ; their probability of transplantation was 30% lower (HR 0.67, 95% CI 0.6-0.7) ( Table 5 ). For wait-listed patients, however, the probability of transplantation no longer differed significantly (HR 1.06, 95% CI 0.94-1.19). The Supplementary materials present the cumulative incidence figures (Supplementary data, Figures  S2-S4) .
Indirect linkage between the two databases was possible for 41 116 patients (78%). The patients not linked were younger and more often female, with lower rates of cardiovascular comorbidities and diabetes. The proportion of CRD was similar in both groups: 13.8% in the linked group versus 12.8% in the other. In 77 394 patient-years on dialysis at risk, 306 059 Adjusted on gender, diabetes, cancer, inability to ambulate, coronary artery disease, congestive heart failure, dysrhythmia, peripheral artery disease, cerebrovascular disease, aortic aneurism, cirrhosis, severe behavioural disorder and BMI (and age in the all group). Patients with CRD had a higher admission rate and more days of hospitalization for all causes and for each cause except cancer, before and after adjustment for age and gender (Table 6 ).
D I S C U S S I O N
In this national cohort of incident ESRD patients, the frequency of CRD at dialysis start was 12% and was associated with other comorbidities. After adjustment for them, CRD remained associated with higher risks of death and hospitalization and lower likelihoods of wait-listing for and actual renal transplantation. In 2013, COPD was the 8th leading cause of years lived with disability [19] and the 12th cause of global years of life lost [20] . COPD, currently the fourth leading cause of death in the USA, will be the third-leading cause of death worldwide by 2020 [21] .
In 2010, reported international prevalence ranged from 0.2% to 37%, but varied widely across countries and populations and by diagnostic and classification methods. Results from NHANES I and III estimate that 24 million Americans have airflow limitation, while only 10 million report a physician diagnosis of COPD or a related disease [22] . The estimated prevalence in France ranges from 1% to 10% [23] .
Few studies have examined the prevalence of COPD in CKD patients. In the 2007-12 NHANES survey, eGFR <60 mL/ min/1.73 m 2 and albuminuria were both associated with impaired lung function [5] . The prevalence of COPD in a Cleveland Clinic CKD cohort was 4.5% [14] . Of 255 Danish haemodialysis patients, 46% had airflow limitation indicative of COPD with the GOLD criteria, but only 9% had previously been diagnosed with COPD [24] . In a US cohort of 769 984 dialysis patients, the prevalence of COPD rose significantly from 6.7% in 1995 to 8.1% in 2004 [3] . Like all general population data, our prevalence of 12.4% is probably underestimated, given the lack of spirometry data; in an international survey, 81.4% of spirometrically defined COPD cases found were previously undiagnosed [25, 26] . Spirometry should be considered for all dialysis patients to ensure dyspnoea is adequately addressed.
As in other studies, patients with CRD were more often male, older, current or past smokers, and had associated comorbidities more often [3, 4, 14, 24] . Unlike some studies [3, 24] , but like others [4, 14] , CRD was associated with diabetes. The associations with cardiovascular comorbidities may result from shared risk factors, including male gender, tobacco use and metabolic syndrome, and also, as mentioned above, subclinical inflammation and endothelial dysfunction [13] . CRD was reported in our study by health-care professionals; without specific pulmonary testing, they might have attributed common symptoms such as dyspnoea to congestive heart failure or CRD. In the Cleveland Clinic CKD registry, overweight (not obesity) was associated with lower risk of COPD, and underweight with higher risk [14] . In our study, underweight was also associated Adjusted on gender, diabetes, cancer, inability to ambulate, coronary artery disease, congestive heart failure, dysrythmia, peripheral artery disease, cerebrovascular disease, aortic aneurism, cirrhosis, severe behavioural disorder and BMI (and age in the all group). 
with a small higher risk of CRD but in contrast with those results [14] , but consistent with others [4, 14] , we found not overweight but obesity associated with higher risk of CRD, perhaps related to diabetes and also to less severe COPD. Sleep apnoea syndrome, frequently reported in dialysis populations [27] , might have been miscoded as CRD. The probability of CRD was higher in former than current smokers. Before the start of dialysis, patients with CRD may more often stop smoking because of their disease than patients without CRD. Smoking CRD patients may also have a higher mortality rates (competing risk of early mortality of smokers) before dialysis. In epidemiology, this is called a Neyman's bias [28] .
As in other studies [3, 4] , the kidney transplantation rate was lower in COPD patients, even after adjustment for numerous clinical conditions. This lower transplantation rate resulted mainly from a lower rate of wait-listing. Clarity about the risks and benefits of transplantation for these patients would help physicians in their decision about putting them on the waiting list.
A Danish study reports that haemodialysis induced a small drop in mean FEV1 and FVC, more pronounced in patients with little or no fluid removal. Nonetheless, dialysis did not affect either the FEV1/FVC ratio or the number of subjects with airflow limitation, indicative of COPD [24] . Hypoxaemia is reported to occur frequently during the first hour of haemodialysis sessions [29] , perhaps due to complement-mediated leucostasis in small pulmonary vessels from bioincompatible dialysis membranes causing an alveolar ventilation/perfusion mismatch. Further, bicarbonate influx during dialysis increases pH and leads to hypoventilation and possibly hypoxaemia [30, 31] .
Death rates from COPD have been rising in the USA over the last decade [32] . This rise is related to increased COPD severity [33] , but its extent is underestimated due to underdiagnosis and underreporting of COPD on death certificates [34] . Its causes of death are mainly cardiovascular and cancer, especially tobacco-related lung cancer [23, 35, 36] . Although the beneficial effect of corticosteroids or bronchodilators or long-term supplemental oxygen on mortality is controversial [35, 37] , smoking cessation improves survival in COPD patients. Oxygen therapy, lung volume reduction surgery and lung transplantation may also improve survival in select patients with advanced disease [35] . As in previous studies, CRD was associated with a 20% higher risk of death even after adjustment for the other comorbidities [3, 14] . This risk was highest in younger age groups and not significant after the age of 85 years. Results are similar for death regardless of the renal replacement therapy used and for death only on dialysis (patients censored when transplanted), because of the low renal transplantation rate during the study period. Cardiovascular diseases were the leading cause of death in both groups. As expected, CRD was associated with a risk of death due to respiratory disease eight times higher than for patients without CRD. Deaths due to infection were slightly more frequent in the CRD group, and deaths from malignancy less frequent. Patients with CRD had higher rates of admission and more hospital days, both overall and for any cause, except cancer. This apparent lower incidence of malignancy in CRD patients may be due to a competing risk upstream from dialysis start; patients with both comorbidities may have chosen not to start dialysis or might have died before it could start.
The major strength of our observational study is our registry's national coverage, the unselected nature of its population and the indirect link with the exhaustive French hospital discharge database. Our findings should, however, be interpreted in light of the following limitations. First, nephrologists defined and determined the presence of CRD, and lack of awareness of this problem in the nephrology community may result in underestimation of its prevalence. Inversely, without specific pulmonary investigations, especially spirometry, symptoms such as dyspnoea may be attributed to CRD although actually due to water and sodium overload, and thus result in overestimating CRD. In addition, some sleep apnoea syndrome may have been recorded as CRD. Secondly, although administrative databases are a powerful resource for epidemiological research, complementing more specific databases, the quality of the linkage in the absence of a unique identifier depends on the information common to the data sets, its quality and the linkage technique.
In conclusion, we observed a frequency of CRD at dialysis start of 12.4% in the REIN registry, which includes all ESRD patients on RRT in France. Among the identified risk factors, obesity and tobacco use were most strongly related to CRD. CRD patients were less frequently wait-listed for kidney transplantation and were hospitalized more often. After adjustment, patients with CRD had a risk of death 20% higher than those without CRD, mainly due to respiratory disease. Improving clinical awareness by patients and doctors and encouraging spirometry use should promote more accurate CRD diagnosis and more appropriate care [21] .
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